Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Daniel Feger"'
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Background Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor with poor prognosis. GMB are highly recurrent mainly because of radio- and chemoresistance. Radiotherapy with Temozolomide (TMZ) is until today the golden st
Externí odkaz:
https://doaj.org/article/7012fe8fc5b94fe288b047c578a19fa0
Publikováno v:
Sensors, Vol 23, Iss 13, p 5846 (2023)
Following up on a proof of concept, this publication presents a new method for mixing mapping on falling liquid films. On falling liquid films, different surfaces, plain or structured, are common. Regarding mixing of different components, the surface
Externí odkaz:
https://doaj.org/article/f94832b51f9a45e7a3504f997f16858a
Publikováno v:
Sensors, Vol 22, Iss 11, p 4086 (2022)
Technical liquid flow films are the basic arrangement for gas fluid transitions of all kinds and are the basis of many chemical processes, such as columns, evaporators, dryers, and different other kinds of fluid/fluid separation units. This publicati
Externí odkaz:
https://doaj.org/article/d096bc55a3ff4daf89435e6ebe672f2a
Publikováno v:
Sensors; Volume 23; Issue 13; Pages: 5846
Following up on a proof of concept, this publication presents a new method for mixing mapping on falling liquid films. On falling liquid films, different surfaces, plain or structured, are common. Regarding mixing of different components, the surface
Autor:
Franziska Fimm-Todt, Ezgi Dikici, Katharina Schaich, Oliver Siedentopf, Joachim Lauterwasser, Daniel Feger, Jan Erik Ehlert
Publikováno v:
Cancer Research. 83:549-549
The proto-oncogene KRas is a well-described small GTPase that functions as a molecular switch for major physiological signaling pathways involved in cell proliferation, differentiation and survival. It has been shown that activating mutations in KRas
Autor:
Vincent Vuaroqueaux, Nadine Obier, Anne-Lise Peille, Daniel Feger, Katharina Schaich, Thomas Metz, Sebastian Dempe, Heinz-Herbert Fiebig, Jan Erik Ehlert
Publikováno v:
Cancer Research. 83:4895-4895
Drug-conjugates are an emerging class of anticancer agents combining the cytotoxic activity of highly potent chemotherapeutic agents with the target specificity of an antibody, a small molecule or a peptide ligand directed against a cancer-associated
Autor:
Carla Castro, Philipp Metzger, Daniel Feger, Sarah Ulrich, Oliver Siedentopf, Jan E. Ehlert, Holger Weber
Publikováno v:
Cancer Research. 83:4419-4419
With the development and approval of cutting-edge immune-based approaches for cancer treatment in recent years, the global immune-oncological (IO) pipelines have dramatically increased. To overcome the challenges of rising treatment resistance, new s
Publikováno v:
Poster Presentations.
Publikováno v:
Cancer Research. 82:2893-2893
Bispecific antibodies are being explored as a means to modulate responses of the immune system to tumor infiltration. They are emerging as a growing class of immunotherapies with potential to further improve clinical efficacy and safety. Besides tumo
Autor:
Vincent Vuaroqueaux, Daniel Feger, Anne-Lise Peille, Oliver Siedentopf, Sadhana Panzade, Sarah Ulrich, Sebastian Dempe, Heinz-Herbert Fiebig, Jan Erik Ehlert
Publikováno v:
Cancer Research. 82:1132-1132
Adavosertib (AZD1775, MK-1775), a clinical stage inhibitor of the tyrosine kinase WEE1, was investigated in a cell proliferation and survival assay with 140 human cancer cell lines (CLs) representing all major tumor types (ProLiFiler platform of Reac